The increasing adoption point of care devices coupled with the increasing awareness among the healthcare professionals regarding the early diagnosis of various diseases has provided a boost to the Latin IVD market. The rising epidemic of communicable diseases in the southernpart of Latin America, the growing need for rapid and accurate diagnostics, and the changing healthcare infrastructure scenario are some of the key drivers of the Latin IVD market.
Further key findings from the study suggest:
The instrument segment is one of the most important segments of in vitro diagnostics. The presence of highly automated analyzers and the availability of over the counter products are some of the factors responsible for its significant share.
The Molecular diagnostics segment is anticipated to be the fastest growing technology over the decade. Molecular diagnostics is a transformative area of diagnostics. The continuous innovation in technology helps the physicians for critical decision making
The infectious disease segment held the largest share in 2015 over 24 % owing to the presence of favorable government initiatives in association with the WHO to curb communicable diseases.
Read Sample report of this Category: http:// www. radiantinsights. com / catalog / biotechnology
The home care segment is estimated to witness a significant growth over the forecast period. The high number of R & D initiatives undertaken by key competitors for the development of portable IVD devices with improved sensitivity and user-friendliness is a key factor attributing towards its growth.
In 2015, Brazil was the largest regional segment with a revenue generation of over USD 1.2 billion owing to the established healthcare infrastructure, growing awareness for cancer screening, and the increasing demand for genetic testing.
Peru is expected to be one of the fastest growing regions on account of the growing economic stability, high unmet clinical needs, and the rising disposable incomes
Key players operating in the Latin America IVD market are Roche Diagnostics, Abbott Laboratories, Inc., Hologic( Gen-Probe), Becton Dickinson( BD) Company, Alere, Inc., Bio-Rad Laboratories, Qiagen N. V., Inc., bioMerieux, BioQuidel Corporation, and Siemens Healthcare.
Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology
Follow Us: